mAbxience |

Jesús
Garicano

Jesús is Quality Director at mAbxience. He brings to the company more than 40 years’ experience in the biotechnological pharmaceutical industry and has worked in all stages of the manufacturing process for biological active substances (both small molecules and proteins): Development of biotechnological processes; modification via biomolecule synthesis; scaling, design and industrialization; validation; manufacture (oral and parenteral); control systems and quality management. 

Jesús began his professional career in 1974 at Antibióticos, S.A., León (Spain) as an R+D technician. He then headed the Chemical Development and Industrialization department in this company and later joined the operations group as Head of Downstream Processes (Purification and modification through synthesis). Finally he became API Quality Management Director (Quality Assurance, Quality Control and Regulatory Affairs), also becoming responsible for the Quality Control of the group’s plants in Italy and Spain. He was involved in the design and commissioning of plants to obtain, purify and finish a wide range of molecules (antibiotics, cytostatics, enzymes, proteins, sterile finish) in Italy, China and Spain. He was involved in several projects for biomolecule development and industrialisation between Antibióticos S.A. and biotechnology companies in various countries (Sweden, Italy, the Netherlands, Great Britain, USA and China).

He was also a Royal Spanish Pharmacopoeia (RFE) advisor for the Spanish Agency for Medicines and Medical Devices (AEMPS, part of the Spanish Ministry of Health) for 11 years and the Spanish EDQM representative (Strasbourg) in group 7 of the European Pharmacopoeia (anti-infective products) for 5 years. He has worked in the preparation of DMFs for APIs with saqual G.m.b.H (CH)

In 2009 he joined the GH GENHELIX project as Quality Management Director and, when the company was acquired by the Chemo group in 2014, he became Quality Management Director at mAbxience.

Jesús has a degree in Organic Chemistry from the University of Zaragoza and he worked for the Spanish National Research Council (CSIC) in the recovery and analysis of complex natural products before joining the  pharmaceutical industry.